Point-of-Care Medical Imaging Market (By Product Type: X-ray, Ultrasound, CT, MRI; By Application: General, Cardiovascular, Vascular; By End-user) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

Market Synopsis

Point-of-care (POC) medical imaging systems are helpful for monitoring patients at the bedside, when transferring patients to the radiology department may be difficult. Traditional imaging systems often run on direct electricity and cords. As a result, in the event of power outages or electrical damage, they can impact service delivery. The batteries in POC systems are strong and operate for a long time. With more service options and better patient care, point-of-care imaging systems enables radiology departments to face challenges head-on. Advances in point-of-care imaging are thus increasing volume and patient satisfaction. 

Market Influencer

The primary factor driving healthcare facilities to adopt point-of-care imaging systems is to enhance patient care, control infections, and rapid diagnosis. Transferring seriously ill patients to the radiology department may result in complications for the patient. As per the, International Journal of Critical Illness & Injury Science, few instances of transport-related consequences include dangers to the respiratory system, traumatic damage, acid-base homeostasis, glucose regulation, the risk for infection, and even fatality. Thus, by bringing diagnostic imaging equipment right to the patient's bedside, patient transportation risks can be eliminated.

During the COVID-19 pandemic, point-of-care imaging systems such as ultrasound and x-rays had proven to be effective in monitoring critically ill patients, and thus, the demand for these systems has only been accelerating. Furthermore, due to the rapid technological improvements in this space, market participants are implementing a variety of strategic activities, including product development and governmental approvals. In August 2020, Hyperfine Research, Inc. received approval for its portable MR imaging device Swoop. The Swoop system is the first POC MRI system in the world that wheels right up to the patient's bedside, plugs into a regular wall outlet, and is operated by a wireless tablet, making MR imaging convenient, quick, and easy.

Key Players

  • GE Healthcare
  • Siemens Healthineers
  • Philips
  • Canon
  • Hyperfine 
  • Neurologica 
  • others

Market Segmentation

  • By Product Type
    • X-ray
    • Ultrasound
    • CT
    • MRI
  • By Application
    • General
    • Cardiovascular
    • Vascular
    • Obstetrics and Gynecology
    • Neurology
    • Urology
    • Others
  • By End-use
    • Hospital
    • Ambulatory Surgical Centers
    • Clinics
    • Homecare
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East & Africa

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Point-of-Care Medical Imaging Market 

5.1. COVID-19 Landscape: Point-of-Care Medical Imaging Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Point-of-Care Medical Imaging Market, By Product Type

8.1. Point-of-Care Medical Imaging Market, by Product Type, 2022-2030

8.1.1 X-ray

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Ultrasound

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. CT

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. MRI

8.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Point-of-Care Medical Imaging Market, By Application

9.1. Point-of-Care Medical Imaging Market, by Application, 2022-2030

9.1.1. General

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Cardiovascular

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Vascular

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Obstetrics and Gynecology

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Neurology

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Urology

9.1.6.1. Market Revenue and Forecast (2017-2030)

9.1.7. Others

9.1.7.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Point-of-Care Medical Imaging Market, By End-use 

10.1. Point-of-Care Medical Imaging Market, by End-use, 2022-2030

10.1.1. Hospital

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Ambulatory Surgical Centers

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Clinics

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Homecare

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Point-of-Care Medical Imaging Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product Type (2017-2030)

11.1.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.3. Market Revenue and Forecast, by End-use (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product Type (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.5.3. Market Revenue and Forecast, by End-use (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product Type (2017-2030)

11.2.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.3. Market Revenue and Forecast, by End-use (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product Type (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.5.3. Market Revenue and Forecast, by End-use (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.6.3. Market Revenue and Forecast, by End-use (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product Type (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.7.3. Market Revenue and Forecast, by End-use (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product Type (2017-2030)

11.3.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.3. Market Revenue and Forecast, by End-use (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product Type (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.5.3. Market Revenue and Forecast, by End-use (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.6.3. Market Revenue and Forecast, by End-use (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product Type (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.7.3. Market Revenue and Forecast, by End-use (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product Type (2017-2030)

11.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product Type (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.5.3. Market Revenue and Forecast, by End-use (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.6.3. Market Revenue and Forecast, by End-use (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product Type (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.7.3. Market Revenue and Forecast, by End-use (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

11.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.3. Market Revenue and Forecast, by End-use (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product Type (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.5.3. Market Revenue and Forecast, by End-use (2017-2030)

Chapter 12. Company Profiles

12.1. GE Healthcare

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Siemens Healthineers

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Philips

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Canon

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Hyperfine

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Neurologica

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. others

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers